1. Home
  2. REAX vs LXEO Comparison

REAX vs LXEO Comparison

Compare REAX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$1.77

Market Cap

437.8M

Sector

N/A

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.73

Market Cap

447.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAX
LXEO
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
437.8M
447.6M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
REAX
LXEO
Price
$1.77
$4.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$5.49
$18.44
AVG Volume (30 Days)
4.7M
653.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.81
EPS
N/A
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$23.04
N/A
Revenue Next Year
$15.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$2.51
52 Week High
$5.41
$10.99

Technical Indicators

Market Signals
Indicator
REAX
LXEO
Relative Strength Index (RSI) 33.18 31.74
Support Level N/A $4.41
Resistance Level $2.57 $5.11
Average True Range (ATR) 0.14 0.38
MACD -0.04 -0.10
Stochastic Oscillator 20.15 6.85

Price Performance

Historical Comparison
REAX
LXEO

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: